Oxford Immunotec (OXFD) Tops Q3 EPS by 15c, Raises Revenue Outlook

November 1, 2016 7:12 AM EDT
Get Alerts OXFD Hot Sheet
Trade OXFD Now!
Join SI Premium – FREE

Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.

Oxford Immunotec (NASDAQ: OXFD) reported Q3 EPS of ($0.18), $0.15 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $26.1 million versus the consensus estimate of $24.79 million.

GUIDANCE:

Oxford Immunotec sees FY2016 revenue of $85-85.8 million, versus prior guidance of $82.5-84.5 million and the consensus of $83.7 million.

For earnings history and earnings-related data on Oxford Immunotec (OXFD) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings, Guidance

Related Entities

Earnings

Add Your Comment